EconomyAbbott plans nutrition business spin-off, lowers 2026 sales growth outlook

Abbott Laboratories said it plans to separate its nutrition business into an independent, publicly traded company and lowered its 2026 sales growth forecast. Its shares fell 3.4% in premarket trading.

Abbott Laboratoriesbusiness spin-offsales outlook

RReuters★★★☆☆2026-10-21 13:15Original